SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001213900-24-081687
Filing Date
2024-09-25
Accepted
2024-09-25 12:55:08
Documents
15

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 11 TO FORM F-1 ea0215636-f1a11_polyrizonltd.htm F-1/A 2382103
2 GRAPHIC img_001.jpg GRAPHIC 11683
3 GRAPHIC img_002.jpg GRAPHIC 7475
4 GRAPHIC img_003.jpg GRAPHIC 5571
5 GRAPHIC img_004.jpg GRAPHIC 6184
6 GRAPHIC img_005.jpg GRAPHIC 5572
7 GRAPHIC img_006.jpg GRAPHIC 8085
8 GRAPHIC img_007.jpg GRAPHIC 7198
9 GRAPHIC img_008.jpg GRAPHIC 6028
10 GRAPHIC img_009.jpg GRAPHIC 5701
11 GRAPHIC img_010.jpg GRAPHIC 6836
12 GRAPHIC img_011.jpg GRAPHIC 8853
13 GRAPHIC img_012.jpg GRAPHIC 13979
14 GRAPHIC img_013.jpg GRAPHIC 3350
15 GRAPHIC img_014.jpg GRAPHIC 3876
  Complete submission text file 0001213900-24-081687.txt   2523207
Mailing Address 12/6 BOROCHOV ST. RAANANA IL 4343306
Business Address 12/6 BOROCHOV ST. RAANANA IL 4343306 972-54-7979668
Polyrizon Ltd. (Filer) CIK: 0001893645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-266745 | Film No.: 241322418
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)